Decreased blood flow of the optic nerve head (MA, MV, and MT measurements) was significantly correlated with increased OSA ...
Building on NSF Leadership Milestones in Sleep Health and SleepTech ® LAS VEGAS, Jan. 7, 2025 /PRNewswire/ -- National Sleep Foundation (NSF), the global voice of sleep health, p ...
Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.
OSA impacts about 936 million people worldwide and occurs when the throat muscles relax and block the airway with a common ...
For about 25 million Americans who suffer from obstructive sleep apnea, there are various effective treatments such as CPAP breathing machines, surgery, a dental mouthpiece and even an implantable pac ...
A recent advisory from the U.S. Surgeon General described the link between drinking alcohol and an increased risk of seven ...
Obese mice whose fat cells were genetically altered to produce an increased amount of the glucose-dependent insulinotropic ...
Women with pregnancy-onset OSA had significantly higher nocturnal systolic BP and daytime diastolic BP, relative to those ...
A growing body of research is finding a robust link between diet and sleep quality. But it’s not just the usual suspects like ...
For individuals with mmOSA, CRP levels were associated with hypertension risk and insulin resistance among those aged less than 60 years.
Adults with obstructive sleep apnea (OSA) are at increased risk for vertigo and vestibular dysfunction, relative to those without OSA.
The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.